MedPath

Alliance for Clinical Trials in Oncology

Alliance for Clinical Trials in Oncology logo
🇺🇸United States
Ownership
Private
Established
2011-01-01
Employees
251
Market Cap
-
Website
https://www.allianceforclinicaltrialsinoncology.org

Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Biological: cetuximab
First Posted Date
2006-01-11
Last Posted Date
2016-12-13
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
21
Registration Number
NCT00275041

Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

Phase 2
Terminated
Conditions
Esophageal Cancer
Interventions
Procedure: conventional surgery
Procedure: neoadjuvant therapy
Radiation: radiation therapy
First Posted Date
2005-12-22
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
27
Registration Number
NCT00268437
Locations
🇺🇸

Rush-Copley Cancer Care Center, Aurora, Illinois, United States

🇺🇸

Graham Hospital, Canton, Illinois, United States

🇺🇸

Mason District Hospital, Havana, Illinois, United States

and more 87 locations

Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
Biological: bevacizumab
First Posted Date
2005-12-22
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
48
Registration Number
NCT00268489
Locations
🇺🇸

Billings Clinic Cancer Center, Billings, Montana, United States

🇺🇸

Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States

🇺🇸

Community Medical Center, Missoula, Montana, United States

and more 243 locations

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Procedure: Therapeutic Conventional Surgery
First Posted Date
2005-12-15
Last Posted Date
2025-04-23
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
622
Registration Number
NCT00265759
Locations
🇺🇸

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, Saint Louis, Missouri, United States

🇺🇸

Doctor's Hospital of Laredo, Laredo, Texas, United States

🇺🇸

M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States

Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2005-12-15
Last Posted Date
2016-12-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
48
Registration Number
NCT00265733

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Phase 3
Completed
Conditions
Colorectal Cancer
Interventions
Biological: bevacizumab
Biological: cetuximab
Drug: FOLFOX or
Drug: FOLFIRI
First Posted Date
2005-12-15
Last Posted Date
2020-05-07
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
2334
Registration Number
NCT00265850
Locations
🇺🇸

Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States

🇺🇸

CCOP - Columbus, Columbus, Ohio, United States

🇺🇸

Northside Hospital Cancer Center, Atlanta, Georgia, United States

and more 677 locations

Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab

Phase 2
Completed
Conditions
Lymphoma
Interventions
Biological: rituximab
First Posted Date
2005-10-13
Last Posted Date
2017-03-15
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
97
Registration Number
NCT00238238
Locations
🇺🇸

Menorah Medical Center, Overland Park, Kansas, United States

🇺🇸

Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States

🇺🇸

Memorial Hospital, Carthage, Illinois, United States

and more 76 locations

Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2005-09-28
Last Posted Date
2016-07-06
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
50
Registration Number
NCT00227565
Locations
🇺🇸

Hennepin County Medical Center - Minneapolis, Minneapolis, Minnesota, United States

🇺🇸

St. Mary - Corwin Regional Medical Center, Pueblo, Colorado, United States

🇺🇸

Rush-Copley Cancer Care Center, Aurora, Illinois, United States

and more 145 locations

American Ginseng in Treating Patients With Cancer-Related Fatigue

Not Applicable
Completed
Conditions
Fatigue
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
Dietary Supplement: American ginseng
Other: Placebo
First Posted Date
2005-09-16
Last Posted Date
2017-10-31
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
290
Registration Number
NCT00182780

Octreotide in Treating Patients With Cancer-Related Malignant Ascites

Phase 3
Completed
Conditions
Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
First Posted Date
2005-09-16
Last Posted Date
2017-04-11
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
33
Registration Number
NCT00182754
Locations
🇺🇸

Swedish Medical Center, Englewood, Colorado, United States

🇺🇸

Bismarck Cancer Center, Bismarck, North Dakota, United States

🇺🇸

Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States

and more 114 locations
© Copyright 2025. All Rights Reserved by MedPath